After years of uncertainty, hospice M&A has reached a clear inflection point. Q4 2025 marked the strongest transaction volume since 2021, driven by premium platform deals that reset valuation benchmarks and restored buyer confidence. As interest rates ease and the valuation gap narrows, private equity is deploying capital more aggressively. According to Cory Mertz, buyers are back—but the bar for clinical integrity and compliance has never been higher.
Behind the Curtain - a webinar series that bridges the gap between healthcare industry buyers and sellers by gathering valuable insights — helping owners understand what drives buyer interest and what may hold them back. This time, Rich Tinsley, CDO at Help at Home shared his insights on what Strategic Buyers really look for in a Home Care M&A.
